These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2554003)

  • 21. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis.
    Montoliu C; Kosenko E; Del Olmo JA; Serra MA; Rodrigo JM; Felipo V
    Liver Int; 2005 Aug; 25(4):787-95. PubMed ID: 15998430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
    Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic and prognostic value of plasma ANP determination after myocardial infarction].
    Neyses L; Biegel H; Heinrichs S; Nitsch J; Lüderitz B
    Z Kardiol; 1988; 77 Suppl 2():51-4. PubMed ID: 2970173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-natriuretic peptide and left ventricular ejection fraction are complementary predictors.
    SoRelle R
    Circulation; 2003 Jun; 107(22):e9048-9. PubMed ID: 12796423
    [No Abstract]   [Full Text] [Related]  

  • 26. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance.
    Ibanez B; Prat-González S; Speidl WS; Vilahur G; Pinero A; Cimmino G; García MJ; Fuster V; Sanz J; Badimon JJ
    Circulation; 2007 Jun; 115(23):2909-16. PubMed ID: 17515460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
    Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
    Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].
    Mazurek W; Salomon P
    Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blunted vascular and renal effects of exogenous atrial natriuretic peptide in patients with cushing's disease.
    Sala C; Ambrosi B; Morganti A
    J Clin Endocrinol Metab; 2001 May; 86(5):1957-61. PubMed ID: 11344191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
    Bald M; Bonzel KE; Rascher W
    Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
    Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H
    Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial.
    Mateos A; García-Lunar I; García-Ruiz JM; Pizarro G; Fernández-Jiménez R; Huertas P; García-Álvarez A; Fernández-Friera L; Bravo J; Flores-Arias J; Barreiro MV; Chayán-Zas L; Corral E; Fuster V; Sánchez-Brunete V; Ibáñez B;
    Ann Emerg Med; 2015 Mar; 65(3):318-24. PubMed ID: 25129820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ANP after AMI.
    Tan AC; van Loenhout TT; Lamfers EJ; Bouwels LH; Kloppenborg PW; Benraad TJ
    Am Heart J; 1990 Dec; 120(6 Pt 1):1484-5. PubMed ID: 2147355
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravenous beta blockade in acute myocardial infarction.
    Jacob AS; Lindsay J
    Am J Cardiol; 1985 Feb; 55(5):622. PubMed ID: 3969927
    [No Abstract]   [Full Text] [Related]  

  • 38. Abstracts of papers presented at an international symposium on the role of beta-blockade in acute myocardial ischaemia and infarction, Rome, October 29-30, 1984.
    Drugs; 1985 Jan; 29 Suppl 1():1-8. PubMed ID: 3882392
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma ANP and systolic function in myocardial infarction.
    Trovato GM; Carpinteri G
    Eur Heart J; 1996 Nov; 17(11):1756. PubMed ID: 8922926
    [No Abstract]   [Full Text] [Related]  

  • 40. Metoprolol for myocardial infarction.
    Blake GJ
    Nursing; 1991 Jan; 21(1):91. PubMed ID: 1988873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.